Boston Scientific wins CE mark for Embold detachable coil system
January 14, 2026
Boston Scientific (NYSE: BSX)+
announced that it received CE mark approval for its Embold detachable coil system.
Boston Scientific (NYSE: BSX)+
announced that it received CE mark approval for its Embold detachable coil system.
Heart disease remains the leading cause of death worldwide, yet progress in understanding and treating cardiac disorders is limited by the shortcomings of existing experimental models. Traditional animal models often fail to capture human-specific cardiac biology, while conventional two-dimensional cell cultures lack the functional and structural complexity of heart tissue.
A new international study led by researchers from UNSW Sydney’s Center for Healthy Brain Aging (CHeBA) has developed the first practical, five-year dementia risk prediction tool for stroke survivors—using only information that’s routinely collected in hospitals and clinics.
A tiny sensor that detects hazardous head impacts the instant they occur could reshape safety monitoring in sports, transportation and other high-risk settings.
Autoimmune diseases such as multiple sclerosis arise when the immune system turns against the body itself. Yet for most of them, it remains unclear why this process begins. Researchers have now identified how the Epstein-Barr virus can, under specific conditions, initiate early multiple sclerosis-like damage in the brain. This offers a new perspective on how rare immune events may shape disease risk.
Sequel Med Tech and Diabeloop today announced a collaboration to integrate a new algorithm into the twiist automated insulin pump.
The protein, known as intelectin-2, also helps to strengthen the mucus barrier lining the digestive tract.
A Boston Scientific (NYSE: BSX)+
executive said on social media that the company received FDA approval for its Farapoint pulsed field ablation (PFA) catheter.
AliveCor announced today that it received FDA clearance for the next generation of its AI technology for the Kardia 12L ECG system.
Minneapolis-based Imricor Medical Systems (ASX:IMR) said it won 510(k) clearance from the FDA for its Vision-MR Diagnostic Catheter.